Clonazepam, a unique benzodiazepine with anticonvulsant and serotonin enhancing capacity, can be used in conjunction with conventional psychopharmacologic agents to treat a variety of psychiatric conditions including schizophrenia, borderline personality disorder, and psychotic mania. Three representative case studies are presented and specific guidelines for the use of clonazepam are discussed.
Get full access to this article
View all access options for this article.
References
1.
ChouinardG.YoungS., and AnnableL., Antimanic Effect of Clonazepam, Biological Psychiatry, 18: 4, pp. 451–466, 1983.
2.
FreinharJ. and AlvarezW., Use of Clonazepam in Two Cases of Acute Mania, Journal of Clinical Psychiatry, 46: 1, pp. 29–30, 1985.
3.
BrownG.GoodwinF.BallengerJ., Aggression in Humans Correlates with Cerebrospinal Fluid Metabolites, Psychiatric Research, 1, pp. 131–139, 1979.
4.
KarsonC.WeinbergerD.BigelowL., Clonzepam Treatment of Chronic Schzophrenia: Negative Results in a Double-Blind, Placebo-Controlled Trial, American Journal of Psychiatry, 139: 12, pp. 1627–1628, 1982.
5.
KleinE.BentalE.LernerB., Carbamazepine and Haloperidol v Placebo and Haloperidol in Excited Psychoses, Archives of General Psychiatry, 41, pp. 165–170, 1984.
6.
ChouinardG., Antipanic Effect of Clonazepam, American Journal of Psychiatry, 141: 1, p. 149, 1984.
